Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;7(3):167-175.
doi: 10.1159/000515541. Epub 2021 Apr 29.

Tackling Dialysis Burden around the World: A Global Challenge

Affiliations

Tackling Dialysis Burden around the World: A Global Challenge

Philip Kam-Tao Li et al. Kidney Dis (Basel). 2021 May.

Abstract

CKD is a global problem that causes significant burden to the healthcare system and the economy in addition to its impact on morbidity and mortality of patients. Around the world, in both developing and developed economies, the nephrologists and governments face the challenges of the need to provide a quality and cost-effective kidney replacement therapy for CKD patients when their kidneys fail. In December 2019, the 3rd International Congress of Chinese Nephrologists was held in Nanjing, China, and in the meeting, a symposium and roundtable discussion on how to deal with this CKD burden was held with opinion leaders from countries and regions around the world, including Australia, Canada, China, Hong Kong, Singapore, Taiwan, the UK, and the USA. The participants concluded that an integrated approach with early detection of CKD, prompt treatment to slow down progression, promotion of home-based dialysis therapy like peritoneal dialysis and home HD, together with promotion of kidney transplantation, are possible effective ways to combat this ongoing worldwide challenge.

Keywords: Chronic kidney disease; End-stage kidney disease; Home dialysis; Kidney transplantation; Prevention.

PubMed Disclaimer

Conflict of interest statement

P.K.T.L. received speaker honorarium from FibroGen and AstraZeneca. W.H.L. received speaker honorarium from Alexion and Astellas and an education grant from Novartis. B.W.T. received honoraria, consulting or speaker fees, or travel support from Böhringer Ingelheim, Novartis, Astellas, Sanofi, Servier, M.S.D., Astra-Zeneca, and Otsuka. X.Q.Y. received research study supports from Baxter Healthcare Corporation, Wanbang company, Kyowa-Kirin, and AstraZeneca. G.S.K. and X.Q.Y. also acted as consultants for Fresenius Kabi, Baxter Healthcare Corporation, and AstraZe­neca. Z.H.L. and J.C.H. are working as editor-in-chief and associate editor, respectively, for Kidney Diseases, and P.K.T.L., J.H.C., and X.Q.Y. are editorial board members for Kidney Diseases.

Figures

Fig. 1
Fig. 1
Regional variation of prevalence of dialysis patients in different provinces showing the uneven distribution in China (Courtesy of Chinese National Renal Data System). pmp, per million population.
Fig. 2
Fig. 2
Incidence rate of RRT in England, Scotland, Wales, and northern Ireland of the UK showing a plateau from 2010 to 2016. (The data reported here have been supplied by the UKRR of the Renal Association. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the UKRR or the Renal Association.) pmp, per million population.
Fig. 3
Fig. 3
Changes in the rate of patients undergoing home dialysis treatment in the USA from 1995 to 2016 (data source: Reference Table D.1 and special analysis, USRDS ESKD Database). ESKD, end-stage kidney disease.

Similar articles

Cited by

References

    1. International Society of Nephrology 2019 United Nations high level meeting on UHC: moving together to build kidney health worldwide. 2019. Retrieved 20 July 2019 https://www.theisn.org/images/Advocacy_4_pager_2019_Final_WEB_pagebypage....
    1. Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, et al. Kidney health for everyone everywhere-from prevention to detection and equitable access to care. Kidney Int. 2020 Feb;97((2)):226–32. - PubMed
    1. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392((10159)):2052–90. - PMC - PubMed
    1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385((9981)):1975–82. - PubMed
    1. Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017;13((7)):393–409. - PubMed